Rituximab is more effective than tacrolimus in steroid-dependent nephrotic syndrome | ADC Education & Practice Edition

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Structured abstracts of sentinel articles: Picket

Rituximab is more effective than tacrolimus in steroid-dependent nephrotic syndrome

Online download statistics by month:

Online download statistics by month: February 2019 to May 2021

	Abstract	Full	Pdf
Feb 2019	510	53	38
Mar 2019	163	21	16
Apr 2019	142	21	11
May 2019	122	8	3
Jun 2019	75	11	7
Jul 2019	75	10	8
Aug 2019	69	7	2
Sep 2019	133	18	11
Oct 2019	200	35	27
Nov 2019	124	19	16
Dec 2019	88	8	10
Jan 2020	113	14	10
Feb 2020	81	11	10
Mar 2020	84	2	3
Apr 2020	63	5	5
May 2020	122	4	6
Jun 2020	54	7	5
Jul 2020	46	9	2
Aug 2020	40	3	4
Sep 2020	105	2	6
Oct 2020	103	5	2
Nov 2020	81	2	1
Dec 2020	47	1	1
Jan 2021	51	0	0
Feb 2021	78	1	0
Mar 2021	56	2	0
Apr 2021	38	1	1
May 2021	32	0	0
Total	2895	280	205